Table 1. BEST1 mutations identified in the patients.
Patient | Age at onset | Mutation | Protein Effect | SIFT | Polyphen-2 | Reported or not |
---|---|---|---|---|---|---|
1 | 13 | c.38G>A/c.763C>T | p.R13H/p.R255W | T/D | B/PrD | Reported/reported |
2 | 29 | c.763C>T/c.763C>T | p.R255W/p.R255W | D/D | PrD/PrD | Reported |
3 | 21 | c.389G>T/c.488T>G | p.R130L/p.M163R | D/D | PrD/PrD | Reported/reported |
4 | 19 | c.842T>C/c.247+2T>G | p.F281S/Splicing defect | D/ NA | PrD/ NA | Novel/novel |
5 | 38 | c.1070C>T/c.1550C>G | p.A357V/p.S517* | D/NA | B/NA | Novel/novel |
6 | 25 | c.764G>A/c.830C>T | p.R255Q/p.T277M | T/D | PrD/PrD | Novel/reported |
7 | 35 | c.1066C>T/ c.1066C>T | p.R356* /p.R356* | NA/ NA | NA/ NA | Reported |
8 | 33 | c.764G>A/c.763C>T | p.R255Q/p.R255W | D/D | PrD/PrD | Novel/reported |
T, Tolerated; D, Damaging; PrD, Probably damaging; B, Benign; NA, No applicable for variants other than amino acid substitution.